TY  - BOOK
ED  - United States.
TI  - Examining concerns regarding FDA's proposed changes to generic drug labeling: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014
AV  - KF27 .E553 2014
PY  - 2016///
CY  - Washington
PB  - U.S. Government Publishing Office
KW  - Generic drugs
KW  - Labeling
KW  - United States
KW  - Drugs
KW  - Safety regulations
KW  - Warning labels
KW  - Government policy
KW  - Legislative hearings
KW  - lcgft
N1  - Shipping list no.: 2016-0177-M; Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office; "Serial No. 113-132."; CRDP Project record; Includes bibliographical references; Microfiche; [Washington, D.C.]; U.S. Government Printing Office; [2016]; 2 microfiches : negative
ER  -